30 Day Trial

Vericel Reports 2Q16 Orthobiologic Revenue

Share:

Vericel posted 2Q16 Carticel revenue of US $9.0MM, -1.1% vs. 2Q15, as reported. 

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.